Trius Therapeutics | The Medical Letter on Drugs and Therapeutics | Journal of Pharmacology and Experimental Therapeutics | Journal of Manipulative and Physiological Therapeutics | Insert key | Esperion Therapeutics | Acorda Therapeutics |
It was developed by Mark E. Davis, professor of Chemical Engineering at the California Institute of Technology, and associates at Insert Therapeutics, Inc., now Calando Pharmaceuticals, Inc., hence the original name "IT-101".